找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology; Stefano Fanti,Gopinath Gnanasegaran,Ignasi Carrió Book 2021 Springe

[复制链接]
查看: 21896|回复: 56
发表于 2025-3-21 19:47:25 | 显示全部楼层 |阅读模式
期刊全称Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology
影响因子2023Stefano Fanti,Gopinath Gnanasegaran,Ignasi Carrió
视频video
发行地址Explores the evaluation of treatment response.Presents Case-based discussions with evidence-based teaching points.Contains High-quality images and excellent authors
图书封面Titlebook: Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology;  Stefano Fanti,Gopinath Gnanasegaran,Ignasi Carrió Book 2021 Springe
影响因子This atlas is a superb guide to the use of PET-CT for the evaluation of treatment response in oncology patients based on its ability to assess tumor metabolic status. The first part of the book explains the role of PET-CT in response evaluation in different treatment settings. For comparison, overviews of the value and limitations of CT alone, PET alone, and anatomical and functional MRI are included. Guidance is also provided on the reporting of PET-CT scans in post-therapy scenarios. The second part of the book describes and illustrates the use of PET-CT with FDG and other tracers to assess the treatment response of malignancies at different anatomic sites. Featuring a wealth of images, informative case-based discussion, and evidence-based teaching points, these disease-specific chapters clearly demonstrate the key role that PET-CT can play in distinguishing early responders from patients who are non-responders or are resistant to treatment. Prompt and accurate evaluation of treatment response is vital as we enter the era of individualized medicine, and this atlas will persuade readers of the considerable advantages of PET-CT over conventional radiological and clinical methods.
Pindex Book 2021
The information of publication is updating

书目名称Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology影响因子(影响力)




书目名称Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology影响因子(影响力)学科排名




书目名称Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology网络公开度




书目名称Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology网络公开度学科排名




书目名称Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology被引频次




书目名称Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology被引频次学科排名




书目名称Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology年度引用




书目名称Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology年度引用学科排名




书目名称Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology读者反馈




书目名称Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:42:32 | 显示全部楼层
Jacqueline Schuldt,Helmut Niegemanns from nonresponders. FDG PET/CT can distinguish viable from the nonviable disease. Still, false positives do occur because of posttreatment inflammatory changes due to the uptake of FDG in macrophages and activated leukocytes. We present multiple case scenarios of FDG PET/CT in response assessment of esophageal and gastric malignancy.
发表于 2025-3-22 01:50:15 | 显示全部楼层
发表于 2025-3-22 05:13:31 | 显示全部楼层
发表于 2025-3-22 10:53:01 | 显示全部楼层
发表于 2025-3-22 13:05:11 | 显示全部楼层
发表于 2025-3-22 17:26:35 | 显示全部楼层
发表于 2025-3-22 23:10:54 | 显示全部楼层
18F-FDG PET/CT and Non 18F-FDG-PET/CT in Treatment Response Evaluation in Neuro-Oncologyo overcome some of the limitations of CE-MRI. There has been significant development in the use of PET imaging for a number of use cases particularly in the field of neuro-oncology. In this chapter, we review examples of several PET Tracers in Treatment Response Evaluation in Neuro-oncology.
发表于 2025-3-23 02:46:44 | 显示全部楼层
PET/CT in the Assessment of Treatment Response in Hepatobiliary, Gall Bladder and Pancreatic Malignase to neoadjuvant therapy and detecting recurrent disease. There are several advantages and limitations of using .F-FDG PET in the assessment of treatment response. This chapter illustrates clinical examples of .F-FDG PET/CT in the assessment of treatment response in hepatobiliary, gall bladder and pancreatic malignancies.
发表于 2025-3-23 06:43:46 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-8 21:29
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表